Damora Therapeutics, Inc. (DMRA): SCHEDULE 13G/A filed May 15, 2026

Form type

SCHEDULE 13G/A

Filing date

May 15, 2026

Accession number

0000919574-26-003477

Filer

Damora Therapeutics, Inc. (CIK 1800315)